- Home
- PROF vs FLC Comparison
PROF vs FLC Comparison
Compare PROF & FLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROF
- FLC
- Stock Information
- Founded
- PROF N/A
- FLC 2003
- Country
- PROF Canada
- FLC United States
- Employees
- PROF N/A
- FLC N/A
- Industry
- PROF Medical/Dental Instruments
- FLC Trusts Except Educational Religious and Charitable
- Sector
- PROF Health Care
- FLC Finance
- Exchange
- PROF Nasdaq
- FLC Nasdaq
- Market Cap
- PROF 164.4M
- FLC 171.6M
- IPO Year
- PROF N/A
- FLC N/A
- Fundamental
- Price
- PROF $4.27
- FLC $16.67
- Analyst Decision
- PROF Strong Buy
- FLC
- Analyst Count
- PROF 2
- FLC 0
- Target Price
- PROF $11.50
- FLC N/A
- AVG Volume (30 Days)
- PROF 79.0K
- FLC 37.8K
- Earning Date
- PROF 05-08-2025
- FLC 01-01-0001
- Dividend Yield
- PROF N/A
- FLC 6.64%
- EPS Growth
- PROF N/A
- FLC N/A
- EPS
- PROF N/A
- FLC N/A
- Revenue
- PROF $11,862,000.00
- FLC N/A
- Revenue This Year
- PROF $71.17
- FLC N/A
- Revenue Next Year
- PROF $134.25
- FLC N/A
- P/E Ratio
- PROF N/A
- FLC N/A
- Revenue Growth
- PROF 75.01
- FLC N/A
- 52 Week Low
- PROF $3.90
- FLC $12.62
- 52 Week High
- PROF $11.42
- FLC $15.45
- Technical
- Relative Strength Index (RSI)
- PROF 34.68
- FLC 61.30
- Support Level
- PROF $4.62
- FLC $15.92
- Resistance Level
- PROF $5.62
- FLC $16.68
- Average True Range (ATR)
- PROF 0.42
- FLC 0.20
- MACD
- PROF -0.01
- FLC 0.07
- Stochastic Oscillator
- PROF 8.45
- FLC 98.79
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
About FLC Flaherty & Crumrine Total Return Fund Inc
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.